DHT & Pattern Hair Loss
What DHT is, what follicle miniaturization means, and why not every kind of shedding is androgenetic alopecia.
Read article →
Ingredient evidence is useful. It becomes garbage when a brand silently jumps from “this molecule was studied” to “our bottle is clinically proven.” We do not make that jump.
What DHT is, what follicle miniaturization means, and why not every kind of shedding is androgenetic alopecia.
Read article →The small AGA pilot, the prostate-tissue DHT study, the route-of-administration problem, and what can responsibly be inferred.
Read article →One oral randomized placebo-controlled trial and one topical randomized comparative trial—plus why neither is a trial of Scalp Defense.
Read article →Those four details matter. An oral supplement trial is not automatically evidence for topical use. A rosemary-oil trial is not automatically evidence for a product that contains some rosemary oil. A prostate-tissue DHT study is mechanistic context—not proof of scalp DHT reduction.
Read the study. Then read the limitations.
Route, dose, formulation and population matter. We keep those details visible so the research stays useful instead of turning into a vague marketing claim.